Filter posts

MERS, Patents, and Material Transfer Agreements: What WHO Didn't Know

The outbreak of the Middle East Respiratory Syndrome (MERS-CoV), a SARS like virus has lead …

Myriad Supreme Court Decision: BIO’s Statement

Statement On U.S. Supreme Court Review Of Isolated DNA Patents Washington, D.C. (June 13, 2013) …

IP in Latin America: Growing Recognition of the Importance of IP to Innovation

The Inter-American Dialogue’s daily Latin America Advisor recently asked the question “How seriously do Latin …

Gene Patents, Angelina Jolie, and Reality

By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization  Angelina …

Kirtsaeng v. John Wiley & Sons: No Good Deed Goes Unpunished

The Supreme Court handed Kirtsaeng a victory last week finding his importation and resale of …

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor Conference

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called …

Brazil Patent Policy: At a Crossroads

The Government of Brazil approaches the patent policy crossroads with two ministries wanting to move …

My family farm isn't under "corporate control"

On CNN’s blog, “Eatocracy”, Indiana farmer Brian Scott challenges the myth that farmers are slaves …

Patently Biotech's Top 5 Articles of 2012

2012 has been an eventful year for biotech IP issues.  Below are the top 5 …

Traditional Knowledge and Genetic Resources: India Misses the Mark

India recently asked the global community for comments on its “Draft Guidelines for Processing of …